20/20 BIOLABS, INC. Debt Instrument, Convertible, Conversion Price
20/20 BIOLABS, INC. (AIDX) had Debt Instrument, Convertible, Conversion Price of $70000000.00 per share as of 2025-12-31, per its POS AM filed 2026-04-06.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2026-04-06
- 2025-12-31: Debt Instrument, Convertible, Conversion Price $70000000.00.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2025-12-31 | $70000000.00 POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |